NasdaqGM - Nasdaq Real Time Price • USD
LeMaitre Vascular, Inc. (LMAT)
As of 12:53 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 7 |
Avg. Estimate | 0.39 | 0.44 | 1.65 | 1.84 |
Low Estimate | 0.37 | 0.4 | 1.64 | 1.78 |
High Estimate | 0.4 | 0.47 | 1.68 | 1.91 |
Year Ago EPS | 0.27 | 0.36 | 1.34 | 1.65 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 7 |
Avg. Estimate | 51.51M | 54.29M | 212.28M | 228.66M |
Low Estimate | 50.84M | 52.6M | 210.5M | 222M |
High Estimate | 51.8M | 55.1M | 216.7M | 238.4M |
Year Ago Sales | 47.08M | 50.12M | 193.48M | 212.28M |
Sales Growth (year/est) | 9.40% | 8.30% | 9.70% | 7.70% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.25 | 0.32 | 0.3 | 0.36 |
EPS Actual | 0.27 | 0.36 | 0.33 | 0.38 |
Difference | 0.02 | 0.04 | 0.03 | 0.02 |
Surprise % | 8.00% | 12.50% | 10.00% | 5.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.39 | 0.44 | 1.65 | 1.84 |
7 Days Ago | 0.39 | 0.44 | 1.65 | 1.84 |
30 Days Ago | 0.39 | 0.44 | 1.65 | 1.84 |
60 Days Ago | 0.34 | 0.41 | 1.53 | 1.67 |
90 Days Ago | 0.35 | 0.4 | 1.52 | 1.67 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | LMAT | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 44.40% | -- | -- | 1.50% |
Next Qtr. | 22.20% | -- | -- | 12.10% |
Current Year | 23.10% | -- | -- | 4.40% |
Next Year | 11.50% | -- | -- | 13.20% |
Next 5 Years (per annum) | 6.00% | -- | -- | 10.97% |
Past 5 Years (per annum) | 6.89% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Upgrade | Stifel: Hold to Buy | 4/26/2024 |
Maintains | Barrington Research: Outperform to Outperform | 2/28/2024 |
Initiated | Keybanc: Sector Weight | 2/6/2024 |
Initiated | JMP Securities: Market Outperform | 10/23/2023 |
Initiated | Oppenheimer: Outperform | 9/6/2023 |
Downgrade | Jefferies: Buy to Hold | 8/3/2023 |
Related Tickers
ICUI ICU Medical, Inc.
95.58
+1.11%
MMSI Merit Medical Systems, Inc.
74.10
+0.97%
GXI.F Gerresheimer AG
99.80
-1.29%
1SXP.F SCHOTT Pharma AG & Co. KGaA
39.68
+1.69%
UTMD Utah Medical Products, Inc.
66.06
-0.35%
SKAN.SW SKAN Group AG
82.00
+0.61%
ATRC AtriCure, Inc.
22.88
+1.17%
HAE Haemonetics Corporation
89.00
+1.53%
KRMD KORU Medical Systems, Inc.
2.2000
+0.46%
TFX Teleflex Incorporated
207.70
+0.48%